Post infusion observation of patients receiving natalizumab in multiple sclerosis patients
Latest Information Update: 20 Jan 2025
Price :
$35 *
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 20 Jan 2025 New trial record